Lipophilic drugs encapsulation in gradient format for tissue engineering applications
The usage of electrospinning to encapsulate drugs that are particularly useful in the differentiation of stem cells has gained attention recently. The drug used in this research is Retinoic acid, which regulates cell growth, homeostasis, and differentiation and is essential in the reversal of...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/39812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | The usage of electrospinning to encapsulate drugs that are particularly useful in the
differentiation of stem cells has gained attention recently. The drug used in this
research is Retinoic acid, which regulates cell growth, homeostasis, and
differentiation and is essential in the reversal of malignant cell growth in vitro and in
vivo. With a continuous sustained drug release from the polymer matrix formed out of
the electrospinning, this can enable the continuous differentiation of the target cells
and possibly advance cancer research. The purpose of this research was to establish a
robust drug release system of the drug retinoic acid through the investigation of
various parameters like applied velocity and polymer concentration to produce a
scaffold that would allow for a sustained continuous drug release of bioactive
Retinoic acid.
Through the research done, it was observed that through varying the applied voltage
for scaffolds of different polymer concentrations, there are applied voltages that will
yield the scaffolds with the most even diameter and with no beads. From there, it was
discovered that 12wt% PCL without gelatin 5-1 TFE-PBS polymer solution yields a
scaffold that is able to release loaded Retinoic acid most consistently out of other
polymer solutions like 12wt% PCL with gelatin 5-1 TFE-PBS and 8wt% PCL with
gelatin 5-1 TFE-PBS. The drug loaded maintained a drug release profile for more
than 40 days. This is essential in ensuring that the drug can be released for a sufficient
amount of time for stem cells to undergo differentiation. |
---|